Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cassie Liu

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Biochemistry|November 9, 2011
Lipopolysaccharide biosynthesis without the lipids: recognition promiscuity of Escherichia coli heptosyltransferase IDaniel J Czyzyk, Cassie Liu, Erika A Taylor
Cancers|July 2, 2021
FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian CancerCassie Liu, Carter J Barger, Adam R Karpf
Journal of Central Nervous System Disease|March 23, 2023
Radiation therapy for pineal parenchymal tumor of intermediate differentiation: A case series and literature reviewCassie Liu, Joseph Carmicheal, Michael J Baine, et al.
Cancer Medicine|March 24, 2025
Disparities Between Rural and Urban Patients With Prostate Cancer in NebraskaCassie Liu, Kaeli K Samson, Oleg Shats, et al.
Cureus|January 9, 2026
Identification of Pancreatic Neuroendocrine Tumor During Evaluation for Severe Valvulopathy in a Patient With a History of Lung Carcinoid Tumor: A Case ReportZhan Rong, Cassie Liu, Christopher Loh, et al.
Nature Protocols|September 23, 2016
Sequencing and cloning of antigen-specific antibodies from mouse memory B cellsLotta von Boehmer, Cassie Liu, Sarah Ackerman, et al.
BMC Medical Genomics|May 27, 2024
Malignant tumors in tuberous sclerosis complex: a case report and review of the literatureCassie Liu, Subodh M Lele, Martin H Goodenberger, et al.
Chemical Biology & Drug Design|July 28, 2010
Using ligand-based virtual screening to allosterically stabilize the activated state of a GPCRChristina M Taylor, Nicole B Rockweiler, Cassie Liu, et al.
Journal of Ovarian Research|May 4, 2024
NB compounds are potent and efficacious FOXM1 inhibitors in high-grade serous ovarian cancer cellsCassie Liu, Makenzie Vorderbruggen, Catalina Muñoz-Trujillo, et al.
Metabolic Engineering|October 25, 2020
Enhanced 2'-Fucosyllactose production by engineered Saccharomyces cerevisiae using xylose as a co-substrateJae Won Lee, Suryang Kwak, Jing-Jing Liu, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Biochemistry|November 9, 2011
Lipopolysaccharide biosynthesis without the lipids: recognition promiscuity of Escherichia coli heptosyltransferase IDaniel J Czyzyk, Cassie Liu, Erika A Taylor
Cancers|July 2, 2021
FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian CancerCassie Liu, Carter J Barger, Adam R Karpf
Journal of Central Nervous System Disease|March 23, 2023
Radiation therapy for pineal parenchymal tumor of intermediate differentiation: A case series and literature reviewCassie Liu, Joseph Carmicheal, Michael J Baine, et al.
Cancer Medicine|March 24, 2025
Disparities Between Rural and Urban Patients With Prostate Cancer in NebraskaCassie Liu, Kaeli K Samson, Oleg Shats, et al.
Cureus|January 9, 2026
Identification of Pancreatic Neuroendocrine Tumor During Evaluation for Severe Valvulopathy in a Patient With a History of Lung Carcinoid Tumor: A Case ReportZhan Rong, Cassie Liu, Christopher Loh, et al.
Nature Protocols|September 23, 2016
Sequencing and cloning of antigen-specific antibodies from mouse memory B cellsLotta von Boehmer, Cassie Liu, Sarah Ackerman, et al.
BMC Medical Genomics|May 27, 2024
Malignant tumors in tuberous sclerosis complex: a case report and review of the literatureCassie Liu, Subodh M Lele, Martin H Goodenberger, et al.
Chemical Biology & Drug Design|July 28, 2010
Using ligand-based virtual screening to allosterically stabilize the activated state of a GPCRChristina M Taylor, Nicole B Rockweiler, Cassie Liu, et al.
Journal of Ovarian Research|May 4, 2024
NB compounds are potent and efficacious FOXM1 inhibitors in high-grade serous ovarian cancer cellsCassie Liu, Makenzie Vorderbruggen, Catalina Muñoz-Trujillo, et al.
Metabolic Engineering|October 25, 2020
Enhanced 2'-Fucosyllactose production by engineered Saccharomyces cerevisiae using xylose as a co-substrateJae Won Lee, Suryang Kwak, Jing-Jing Liu, et al.
Pageof 2